These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

375 related items for PubMed ID: 14696115

  • 1. Regulation of carcinoma cell invasion by protein C inhibitor whose expression is decreased in renal cell carcinoma.
    Wakita T, Hayashi T, Nishioka J, Tamaru H, Akita N, Asanuma K, Kamada H, Gabazza EC, Ido M, Kawamura J, Suzuki K.
    Int J Cancer; 2004 Feb 10; 108(4):516-23. PubMed ID: 14696115
    [Abstract] [Full Text] [Related]

  • 2. Protein C and its inhibitor in malignancy.
    Suzuki K, Hayashi T.
    Semin Thromb Hemost; 2007 Oct 10; 33(7):667-72. PubMed ID: 18000793
    [Abstract] [Full Text] [Related]

  • 3. Connexin 32 down-regulates the fibrinolytic factors in metastatic renal cell carcinoma cells.
    Hagiwara H, Sato H, Shirai S, Kobayashi S, Fukumoto K, Ishida T, Seki T, Ariga T, Yano T.
    Life Sci; 2006 Apr 04; 78(19):2249-54. PubMed ID: 16289236
    [Abstract] [Full Text] [Related]

  • 4. Differential gene expression of urokinase-type plasminogen activator and its receptor in human renal cell carcinoma.
    Bhuvarahamurthy V, Schroeder J, Kristiansen G, Roigas J, Denkert C, Johannsen M, Lein M, Loening SA, Schnorr D, Jung K, Staack A.
    Oncol Rep; 2005 Sep 04; 14(3):777-82. PubMed ID: 16077991
    [Abstract] [Full Text] [Related]

  • 5. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.
    Hildenbrand R, Schaaf A.
    Int J Oncol; 2009 Jan 04; 34(1):15-23. PubMed ID: 19082473
    [Abstract] [Full Text] [Related]

  • 6. Expressions of urokinase-type plasminogen activator, its receptor and plasminogen activator inhibitor-1 in gastric cancer cells and effects of Helicobacter pylori.
    Iwamoto J, Mizokami Y, Takahashi K, Nakajima K, Ohtsubo T, Miura S, Narasaka T, Takeyama H, Omata T, Shimokobe K, Ito M, Takehara H, Matsuoka T.
    Scand J Gastroenterol; 2005 Jul 04; 40(7):783-93. PubMed ID: 16109653
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of MMP-9 using a pyrrole-imidazole polyamide reduces cell invasion in renal cell carcinoma.
    Sato A, Nagase H, Obinata D, Fujiwara K, Fukuda N, Soma M, Yamaguchi K, Kawata N, Takahashi S.
    Int J Oncol; 2013 Nov 04; 43(5):1441-6. PubMed ID: 23969530
    [Abstract] [Full Text] [Related]

  • 8. Expression of urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor and plasminogen activator inhibitors in patients with renal cell carcinoma: correlation with tumor associated macrophage and prognosis.
    Ohba K, Miyata Y, Kanda S, Koga S, Hayashi T, Kanetake H.
    J Urol; 2005 Aug 04; 174(2):461-5. PubMed ID: 16006865
    [Abstract] [Full Text] [Related]

  • 9. Modulation of urokinase and urokinase receptor gene expression in human renal cell carcinoma.
    Wagner SN, Atkinson MJ, Thanner S, Wagner C, Schmitt M, Wilhelm O, Rotter M, Höfler H.
    Am J Pathol; 1995 Jul 04; 147(1):183-92. PubMed ID: 7604879
    [Abstract] [Full Text] [Related]

  • 10. ZEB1 Promotes invasiveness of colorectal carcinoma cells through the opposing regulation of uPA and PAI-1.
    Sánchez-Tilló E, de Barrios O, Siles L, Amendola PG, Darling DS, Cuatrecasas M, Castells A, Postigo A.
    Clin Cancer Res; 2013 Mar 01; 19(5):1071-82. PubMed ID: 23340304
    [Abstract] [Full Text] [Related]

  • 11. Quantitative RT-PCR assays for the determination of urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 mRNA in primary tumor tissue of breast cancer patients: comparison to antigen quantification by ELISA.
    Biermann JC, Holzscheiter L, Kotzsch M, Luther T, Kiechle-Bahat M, Sweep FC, Span PN, Schmitt M, Magdolen V.
    Int J Mol Med; 2008 Feb 01; 21(2):251-9. PubMed ID: 18204793
    [Abstract] [Full Text] [Related]

  • 12. Urokinase plasminogen activator, uPa receptor, and its inhibitor in vernal keratoconjunctivitis.
    Leonardi A, Brun P, Sartori MT, Cortivo R, Dedominicis C, Saggiorato G, Abatangelo G, Secchi AG.
    Invest Ophthalmol Vis Sci; 2005 Apr 01; 46(4):1364-70. PubMed ID: 15790903
    [Abstract] [Full Text] [Related]

  • 13. Expression and prognostic significance of urokinase and plasminogen activator inhibitor type-1 in endometrial hyperplasia and cancer.
    Taponeco F, Curcio C, Giuntini A, Nardini V, Fornaciari G, Artini PG, D'Ambrogio G, Genazzani AR.
    J Exp Clin Cancer Res; 2001 Jun 01; 20(2):239-46. PubMed ID: 11484981
    [Abstract] [Full Text] [Related]

  • 14. Suppression of invasion and peritoneal carcinomatosis of ovarian cancer cell line by overexpression of bikunin.
    Suzuki M, Kobayashi H, Tanaka Y, Hirashima Y, Kanayama N, Takei Y, Saga Y, Suzuki M, Itoh H, Terao T.
    Int J Cancer; 2003 Apr 10; 104(3):289-302. PubMed ID: 12569552
    [Abstract] [Full Text] [Related]

  • 15. Calcitonin inhibits invasion of breast cancer cells: involvement of urokinase-type plasminogen activator (uPA) and uPA receptor.
    Han B, Nakamura M, Zhou G, Ishii A, Nakamura A, Bai Y, Mori I, Kakudo K.
    Int J Oncol; 2006 Apr 10; 28(4):807-14. PubMed ID: 16525628
    [Abstract] [Full Text] [Related]

  • 16. The inhibitory effect of connexin 32 gene on metastasis in renal cell carcinoma.
    Sato H, Hagiwara H, Senba H, Fukumoto K, Nagashima Y, Yamasaki H, Ueno K, Yano T.
    Mol Carcinog; 2008 Jun 10; 47(6):403-9. PubMed ID: 18058801
    [Abstract] [Full Text] [Related]

  • 17. Type-1 plasminogen activator inhibitor in human renal cell carcinoma.
    Wagner SN, Atkinson MJ, Thanner S, Schmitt M, Wilhelm O, Rotter M, Höfler H.
    J Pathol; 1996 May 10; 179(1):95-9. PubMed ID: 8691352
    [Abstract] [Full Text] [Related]

  • 18. miR-96 suppresses renal cell carcinoma invasion via downregulation of Ezrin expression.
    Yu N, Fu S, Liu Y, Xu Z, Liu Y, Hao J, Wang B, Zhang A.
    J Exp Clin Cancer Res; 2015 Sep 29; 34():107. PubMed ID: 26419932
    [Abstract] [Full Text] [Related]

  • 19. Metastin inhibits migration and invasion of renal cell carcinoma with overexpression of metastin receptor.
    Shoji S, Tang XY, Umemura S, Itoh J, Takekoshi S, Shima M, Usui Y, Nagata Y, Uchida T, Osamura RY, Terachi T.
    Eur Urol; 2009 Feb 29; 55(2):441-9. PubMed ID: 18395325
    [Abstract] [Full Text] [Related]

  • 20. Intracellular localization of protein C inhibitor (PCI) and urinary plasminogen activator in renal tubular epithelial cells from humans and human PCI gene transgenic mice.
    Song Z, Ma N, Hayashi T, Gabazza EC, Sugimura Y, Suzuki K.
    Histochem Cell Biol; 2007 Oct 29; 128(4):293-300. PubMed ID: 18193533
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.